SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-20-050053
Filing Date
2020-04-23
Accepted
2020-04-23 09:03:44
Documents
2
Effectiveness Date
2020-04-23

Document Format Files

Seq Description Document Type Size
1 DEFA14A tm202033d2_defa14a.htm DEFA14A 21349
2 GRAPHIC tm202033d2_defa14aimg001.jpg GRAPHIC 352927
  Complete submission text file 0001104659-20-050053.txt   508733
Mailing Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333
Business Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333 484-581-7505
Zynerba Pharmaceuticals, Inc. (Filer) CIK: 0001621443 (see all company filings)

IRS No.: 260389433 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37526 | Film No.: 20809392
SIC: 2834 Pharmaceutical Preparations